These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7004020)

  • 1. [Phage conversion of toxigenicity in Clostridium botulinum].
    Khotenko SG; Perova EV; Golikov VI; Bulatova TI; Il'iashenko BN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):25-8. PubMed ID: 7004020
    [No Abstract]   [Full Text] [Related]  

  • 2. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Iida H; Oguma K; Inoue K
    Jpn J Med Sci Biol; 1974 Apr; 27(2):101-3. PubMed ID: 4601039
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriophage and toxigenicity in Clostridium botulinum: an additional evidence for phage conversion.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1973 Sep; 17(5):425-6. PubMed ID: 4587764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxin production and phage in Clostridium botulinum].
    Iida H
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):827-34. PubMed ID: 3908743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxigenicity and bacteriophages of Clostridium botulinum].
    Oguma K
    Nihon Saikingaku Zasshi; 1974 Jul; 29(4):665-9. PubMed ID: 4613878
    [No Abstract]   [Full Text] [Related]  

  • 6. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxins: more and more diverse and fascinating toxic proteins.
    Popoff MR
    J Infect Dis; 2014 Jan; 209(2):168-9. PubMed ID: 24106294
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium botulinum toxin statement from the director of the California Department of Public Health.
    Chapman R
    J Infect Dis; 2014 Nov; 210(9):1517. PubMed ID: 24808389
    [No Abstract]   [Full Text] [Related]  

  • 10. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 38 degrees to 50 degrees F. TID-25231.
    Eklund MW; Poysky FT
    TID Rep; 1969 Jan; ():1-33. PubMed ID: 4905817
    [No Abstract]   [Full Text] [Related]  

  • 12. Validity of botulinum neurotoxin serotype H.
    Johnson EA
    J Infect Dis; 2014 Sep; 210(6):992-3; discussion 993. PubMed ID: 24723473
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Korch.
    Hooper DC; Hirsch MS
    J Infect Dis; 2014 Nov; 210(9):1517-8. PubMed ID: 24808388
    [No Abstract]   [Full Text] [Related]  

  • 14. "Inconvenient truths" in the pursuit of scientific knowledge and public health.
    Relman DA
    J Infect Dis; 2014 Jan; 209(2):170-2. PubMed ID: 24106297
    [No Abstract]   [Full Text] [Related]  

  • 15. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two inducible bacteriophages, alpha 1 and alpha 2, isolated from Clostridium botulinum type A 190L and their deoxyribonucleic acids.
    Kinouchi T; Takumi K; Kawata T
    Microbiol Immunol; 1981; 25(9):915-27. PubMed ID: 6273702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 18. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Iida H; Sugiyama H
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract]   [Full Text] [Related]  

  • 20. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny.
    Sakaguchi Y; Hayashi T; Kurokawa K; Nakayama K; Oshima K; Fujinaga Y; Ohnishi M; Ohtsubo E; Hattori M; Oguma K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17472-7. PubMed ID: 16287978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.